Posted inBiotechnology
Posted inBiotechnology
Reviva’s antipsychotic shows promise against schizophrenia symptoms in year-long study
In the wake of the approval Bristol Myers Squibb’s Cobenfy, it seems that news has ramped up in the schizophrenia…























